🏛️ Verified NIH Record • Updated 2026-03-23
A Study to Evaluate the Immune Response and Safety of an Influenza Vaccine in Adults 18 Years of Age and Above (NCT07204964)
A Phase 2a Randomized, Observer-Blind, Study to Evaluate the Immunogenicity and Safety of mRNA-Based Multivalent Seasonal Influenza Vaccine Candidates in Adults 18 Years of Age and Older
🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic Sponsor: GlaxoSmithKline
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is to assess the reactogenicity, safety and immune response of GlaxoSmithKline's (GSK) messenger RNA (mRNA)-based multivalent seasonal influenza vaccine candidates administered in healthy younger and older adults.
Who can join: Review the eligibility criteria below.
Location: GSK Investigational Site — Guntersville, Alabama
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (17 Sites)
- GSK Investigational Site — Guntersville, Alabama
- GSK Investigational Site — Canoga Park, California
- GSK Investigational Site — Walnut Creek, California
- GSK Investigational Site — Hialeah, Florida
- GSK Investigational Site — Miami, Florida
- GSK Investigational Site — Pembroke Pines, Florida
- GSK Investigational Site — Stockbridge, Georgia
- GSK Investigational Site — Carson City, Nevada
- GSK Investigational Site — Las Vegas, Nevada
- GSK Investigational Site — Greensboro, North Carolina
- GSK Investigational Site — North Charleston, South Carolina
- GSK Investigational Site — Austin, Texas
- GSK Investigational Site — Garland, Texas
- GSK Investigational Site — Newport News, Virginia
- GSK Investigational Site — Seattle, Washington
- GSK Investigational Site — Edegem,
- GSK Investigational Site — Ghent,
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Influenza, Human
- Characterization of Humoral and Cellular Immune Responses Elicited by Influenza Vaccination in Healthy Adults — Philadelphia, Pennsylvania
Explore by condition: All Influenza, Human clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.